Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 03, 2009 | Chief Medical Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 100,000 | -- | 100,000 | |
| Feb 03, 2009 | VP, Business Operations | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 36,000 | -- | 36,000 | |
| Feb 03, 2009 | Director, President & CEO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 103,500 | -- | 103,500 | |
| Feb 03, 2009 | Chief Financial Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 54,000 | -- | 54,000 | |
| Feb 03, 2009 | SVP & General Counsel | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 31,500 | -- | 31,500 | |
| Feb 03, 2009 | VP, Regulatory Affairs | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 22,500 | -- | 22,500 | |
| Feb 03, 2009 | VP, Medical Affairs | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 27,000 | -- | 27,000 | |
| Feb 03, 2009 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 54,000 | -- | 54,000 | |
| Feb 03, 2009 | Senior VP, Technical Operation | Open market or private sale of non-derivative or derivative security | Form 4 | 7,500 | $10.00 | 46,540 | |
| Feb 03, 2009 | Senior VP, Technical Operation | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 18,000 | -- | 18,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.